Pfizer Inc. today announced results from the pivotal Phase 3 CREST trial of sasanlimab, an investigational anti-PD-1 monoclonal antibody (mAb), in combination with standard of care (SOC) Bacillus ...

Steffens has turned his passion for the field into a thriving business enterprise. Steffens opened his third location for a ...